The abstract is read at the publisher; the summary is JClub's.
GT-AST predicts minimum inhibitory concentrations from ~2 h glucose-turbidity trajectories, achieving 87.1% essential agreement with reference MICs across 100 repeats of isolate-grouped cross-validation.
- Why it matters: Standard broth microdilution waits for overnight growth, delaying antibiotic selection; pairing metabolic signals with early growth dynamics could enable faster susceptibility readouts.
- What they did: They developed glucose-turbidity antimicrobial susceptibility testing (GT-AST) that links residual-glucose assay signals with turbidity, then uses early trajectories to predict subsequent growth and MICs.
- The result: In eight bronchoalveolar lavage specimens, levofloxacin classifications matched hospital results in all four culture-positive samples, and predicted versus hospital MICs showed 99.0% exact and 99.0% essential agreement.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.